WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development
SHANGHAI, Jan. 31, 2024 /PRNewswire/ — WuXi XDC ( […]
News from PR Newswire
SHANGHAI, Jan. 31, 2024 /PRNewswire/ — WuXi XDC ( […]
BEIJING, Jan. 31, 2024 /PRNewswire/ — As part of […]
2023 marked a terrific year for Marriott International […]